Pneumonia: Difference between revisions
| Line 37: | Line 37: | ||
==Case Studies== | ==Case Studies== | ||
[[Pneumonia case study one|Case #1]] | [[Pneumonia case study one|Case #1]] | ||
==Related Chapters== | |||
*[[Pneumocystis Carinii pneumonia]] | |||
*[[Atypial pneumonia]] | |||
*[[Mycoplasma pneumonia]] | |||
*[[Eosinophilic pneumonia]] | |||
* | |||
[[Category:Disease]] | [[Category:Disease]] | ||
Revision as of 13:45, 11 December 2014
|
Pneumonia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pneumonia On the Web |
|
American Roentgen Ray Society Images of Pneumonia |
For patient information click here
Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]; Priyamvada Singh, M.D. [3]; Philip Marcus, M.D., M.P.H.[4]
Overview
Historical Perspective
Classification
Community-Acquired Pneumonia | Hospital-Acquired Pneumonia
Pathophysiology
Causes
Caused by pathogen: Bacterial | Viral | Fungal
Differentiating Pneumonia from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Prognosis Predictor Scores: CURB-65 | Pneumonia Severity Index | Criteria for Severe Community-Acquired Pneumonia
Diagnosis
Diagnostic Criteria | Diagnostic Algorithm | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | Other Imaging Findings
Treatment
Medical Therapy | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies